ANDA 60174, held by Ferrante. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 60174 (Tetracycline Hydrochloride), held by Ferrante, was first approved by FDA on Oct 22, 1964, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 22, 1964 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tetracycline Hydrochloride125MG/5ML ยท suspension;oral | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters